MRNA vs TEAM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 06, 2026

MRNA

48.8
AI Score
VS
TEAM Wins

TEAM

52.8
AI Score

Investment Advisor Scores

MRNA

49score
Recommendation
HOLD

TEAM

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MRNA TEAM Winner
Revenue 534.00M 4.81B TEAM
Net Income -2.13B -192.90M TEAM
Net Margin -397.9% -4.0% TEAM
Operating Income -2.20B -200.37M TEAM
ROE -31.4% -21.9% TEAM
ROA -19.4% -3.4% TEAM
Total Assets 10.96B 5.65B MRNA
Cash 1.72B 1.14B MRNA
Debt/Equity 0.09 1.13 MRNA
Current Ratio 2.29 0.70 MRNA
Free Cash Flow -1.25B 844.38M TEAM

Relative Price Performance (Last 90 Days)

MRNA 1M: -23.7% · 3M: +20.3% TEAM 1M: +63.8% · 3M: +60.9%

Current Technical Phase

MRNA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.0 · Price: $58.39

TEAM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.3% over 20 days), RSI 78

RSI (14): 78.5 · Price: $148.58

Fundamentals Snapshot

Metric MRNA TEAM
Market Cap
Forward P/E -11.0 24.5
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.3%
Gross Margin -0.7% 0.8%
Operating Margin -5.6% 0.1%
EPS -7.88 -0.79
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, TEAM is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.